The metabolism of cancer cells during metastasis
G Bergers, SM Fendt - Nature Reviews Cancer, 2021 - nature.com
Metastasis formation is the major cause of death in most patients with cancer. Despite
extensive research, targeting metastatic seeding and colonization is still an unresolved …
extensive research, targeting metastatic seeding and colonization is still an unresolved …
[HTML][HTML] Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies
Z Wang, F Liu, N Fan, C Zhou, D Li, T Macvicar… - Frontiers in …, 2020 - frontiersin.org
Metabolism rewiring is an important hallmark of cancers. Being one of the most abundant
free amino acids in the human blood, glutamine supports bioenergetics and biosynthesis …
free amino acids in the human blood, glutamine supports bioenergetics and biosynthesis …
[HTML][HTML] Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy
M Van Trimpont, E Peeters, Y De Visser, AM Schalk… - Cancers, 2022 - mdpi.com
Simple Summary L-asparaginase (L-ASNase) therapy is key for achieving the very high cure
rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this …
rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this …
[HTML][HTML] Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia
M Chiu, G Taurino, MG Bianchi, MS Kilberg… - Frontiers in …, 2020 - frontiersin.org
Asparagine Synthetase (ASNS) catalyzes the synthesis of the non-essential amino acid
asparagine (Asn) from aspartate (Asp) and glutamine (Gln). ASNS expression is highly …
asparagine (Asn) from aspartate (Asp) and glutamine (Gln). ASNS expression is highly …
Identification of a four‐gene metabolic signature predicting overall survival for hepatocellular carcinoma
GM Liu, WX Xie, CY Zhang… - Journal of cellular …, 2020 - Wiley Online Library
While hundreds of consistently altered metabolic genes had been identified in
hepatocellular carcinoma (HCC), the prognostic role of them remains to be further …
hepatocellular carcinoma (HCC), the prognostic role of them remains to be further …
GOT2 silencing promotes reprogramming of glutamine metabolism and sensitizes hepatocellular carcinoma to glutaminase inhibitors
Hepatocellular carcinoma (HCC) is one of the primary liver malignancies with a poor
prognosis. Glutamic-oxaloacetic transaminase 2 (GOT2) is a highly tissue-specific gene in …
prognosis. Glutamic-oxaloacetic transaminase 2 (GOT2) is a highly tissue-specific gene in …
Cascaded filter deterministic lateral displacement microchips for isolation and molecular analysis of circulating tumor cells and fusion cells
Precise isolation and analysis of circulating tumor cells (CTCs) from blood samples offer
considerable potential for cancer research and personalized treatment. Currently, available …
considerable potential for cancer research and personalized treatment. Currently, available …
The role of SOX family transcription factors in gastric cancer
AJ Abadi, A Zarrabi, F Hashemi, A Zabolian… - International journal of …, 2021 - Elsevier
Gastric cancer (GC) is a leading cause of death worldwide. GC is the third-most common
cause of cancer-related death after lung and colorectal cancer. It is also the fifth-most …
cause of cancer-related death after lung and colorectal cancer. It is also the fifth-most …
MiR‐125b loss activated HIF1α/pAKT loop, leading to transarterial chemoembolization resistance in hepatocellular carcinoma
X Wei, L Zhao, R Ren, F Ji, S Xue, J Zhang, Z Liu… - …, 2021 - Wiley Online Library
Background and Aims Transarterial chemoembolization (TACE) is a standard locoregional
therapy for patients with hepatocellular carcinoma (HCC) patients with a variable overall …
therapy for patients with hepatocellular carcinoma (HCC) patients with a variable overall …
[HTML][HTML] Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
J Zhang, S Zou, L Fang - Cell & Bioscience, 2023 - Springer
With high prevalence and mortality, together with metabolic reprogramming, colorectal
cancer is a leading cause of cancer-related death. Metabolic reprogramming gives tumors …
cancer is a leading cause of cancer-related death. Metabolic reprogramming gives tumors …